SAT0164 The First Study of Certolizumab Pegol in Combination with Methotrexate in Dmard-Naïve Early Rheumatoid Arthritis Patients Led to Sustained Clinical Response and Inhibition of Radiographic Progression at 52 Weeks: The C-Early Randomized, Double-Blind, Controlled Phase 3 Study
Year: 2015
Type: conference-abstract
Source: Annals of the Rheumatic Diseases
Institutions: University of Leeds, Johns Hopkins University, Charité – Universitätsmedizin Berlin, Hospital for Special Surgery, Cornell University, University of California, Los Angeles, Université Paris-Sud, Assistance Publique – Hôpitaux de Paris, Hôpitaux universitaires Paris Sud, Leiden University Medical Center, UCB Pharma (United States), UCB Pharma (Belgium), Brigham and Women's Hospital
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2418821077